Jennison Associates’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,054
Closed -$702K 606
2024
Q2
$702K Sell
16,054
-5,157
-24% -$249K ﹤0.01% 515
2024
Q1
$1.01M Buy
21,211
+1,623
+8% +$72.9K ﹤0.01% 498
2023
Q4
$925K Buy
19,588
+249
+1% +$10.3K ﹤0.01% 500
2023
Q3
$921K Sell
19,339
-1,499
-7% -$81.8K ﹤0.01% 479
2023
Q2
$1.21M Buy
+20,838
New +$1.25M ﹤0.01% 465
2021
Q3
Sell
-13,480
Closed -$1.1M 704
2021
Q2
$1.1M Sell
13,480
-9,614
-42% -$773K ﹤0.01% 618
2021
Q1
$1.74M Buy
+23,094
New +$1.68M ﹤0.01% 557

Other funds holding NGVT

Jennison Associates's NGVT Position: Q3 2024 in Review

Jennison Associates sold out of Ingevity (NGVT) in Q3 2024, closing a stake of 16,054 shares — an estimated $702K sold.

Jennison Associates first reported a position in NGVT in Q1 2021 and held it in 7 quarters. The position peaked at $1.74M in Q1 2021. 261 funds tracked by Wall St. Rank hold NGVT as of Q3 2024.

  • Jennison Associates reported no remaining Ingevity position as of Q3 2024 after selling out during the quarter.
  • Jennison Associates sold 16,054 Ingevity shares in Q3 2024, an estimated $702K.
  • Jennison Associates first reported a position in Ingevity in Q1 2021 and held it in 7 quarters.
  • Jennison Associates's Ingevity position peaked at $1.74M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held Ingevity as of Q3 2024.

Based on Jennison Associates's 13F filing for Q3 2024, filed 8 Nov 2024.